Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications
Launched by ST. PETER'S HOSPITAL, ALBANY, NY · Jan 3, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background
Diabetes and variations in glucose control are comorbidities that increase complications in the surgical patient (Harris, 2018). Insulin signaling is impaired during surgery and transient insulin resistance develops. Decreased circulating insulin levels lead to a physiological hyperglycemic response that lasts 24 to 48 hours after surgery. Surgeries involving the chest and abdomen have a longer and more pronounced degree of hyperglycemia reaction in the body (Peacock, 2019). The prevalence of surgical site infections (SSIs) in surgical patients across the United States has gaine...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Any adult surgical patient who undergoes a procedure expecting to last 2 or more hours regardless of age, gender, race, sex, religion, nation of origin, or other identifiable demographics -
- • Exclusion Criteria: Type 1 Diabetes or other patients with strick endocrinology orders
- • -
About St. Peter's Hospital, Albany, Ny
St. Peter's Hospital, located in Albany, New York, is a leading healthcare institution dedicated to providing high-quality patient care and advancing medical research. As a clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving health outcomes. With a commitment to patient safety and ethical standards, St. Peter's Hospital collaborates with a diverse team of healthcare professionals and researchers to conduct rigorous clinical trials across various therapeutic areas. This dedication to clinical excellence not only enhances the hospital's clinical offerings but also contributes to the broader medical community's knowledge and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albany, New York, United States
Patients applied
Trial Officials
Jamila Benmoussa, MD
Study Director
St. Peter's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported